已收盤 05-08 16:00:00 美东时间
-2.050
-3.76%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Oppenheimer analyst Rupesh Parikh maintains Prestige Consumer (NYSE:PBH) with a Outperform and lowers the price target from $77 to $65.
05-07 20:56
Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portfolio into sleep & breathing categories.
03-20 19:56
Prestige Consumer Healthcare (PBH) to acquire the Breathe Right brand and other over-the-counter health products from Foundation Consumer Brands for $1.045 billion in cash under a definitive agreement...
03-20 18:33
Prestige Consumer Healthcare Inc. announced an agreement to acquire the Breathe Right® brand and other brands from Foundation Consumer Healthcare for $1.045 billion, net $900 million. Breathe Right, a leading nasal strip brand, expands Prestige’s portfolio into the sleep and better-breathing categories. The acquisition includes Dimetapp® and other established brands. Financial highlights: $200 million revenue, $95 million EBITDA, attractive mar...
03-20 10:15
Companies Reporting Before The Bell • Neuraxis (AMEX:NRXS) is projected to repo...
03-19 19:11
Senior VP Operations Jeffrey Zerillo Sells Prestige Consumer Healthcare Inc. Common Shares Jeffrey Zerillo, Senior Vice President of Operations at Prestige Consumer Healthcare Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaime
02-14 05:38
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. VANCOUVER, BC, Feb. 13, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global health and wellness sector is entering 2026 on a traj...
02-14 00:26
华盛资讯2月7日讯,普雷斯蒂奇公布2025财年Q4业绩,公司Q4营收2.83亿美元,同比下降2.4%,归母净利润0.47亿美元,同比下滑23.5%。
02-07 08:17
华盛资讯2月6日讯,普雷斯蒂奇公布2025财年Q4业绩,公司Q4营收2.83亿美元,同比下降2.4%,归母净利润0.47亿美元,同比下滑23.0%。
02-06 15:38